Investment Rating - The report maintains a "Buy" rating for the MIM industry, highlighting its core advantages in high-end precision manufacturing [5]. Core Insights - The MIM process, characterized by near-net shaping and high material utilization, is becoming a key technology in high-end precision manufacturing. The demand for small, precise, and integrated components in humanoid robots aligns well with MIM technology, which is increasingly being adopted by leading manufacturers like Figure [6][7]. - The MIM market in China is expected to grow significantly, reaching approximately 14.14 billion yuan by 2026, with a global market share increase to 31.2% [5][61]. Summary by Sections 1. MIM Process and Technology - The MIM process combines the advantages of plastic injection molding and powder metallurgy, allowing for the production of complex three-dimensional shapes with high density and strength, surpassing traditional powder metallurgy [10][17]. - MIM's core advantages include high forming capability, excellent material utilization, uniform microstructure, high production efficiency, and strong material adaptability [32][36]. 2. MIM Market Overview - The global MIM market reached approximately $3.776 billion in 2022 and is projected to grow to $7.388 billion by 2029, with a CAGR of 10.7% [52][57]. - In China, the MIM market was valued at about 9.12 billion yuan in 2022, with expectations to reach 14.14 billion yuan by 2026, indicating a strong growth trajectory [61][62]. 3. Application Areas - The primary application of MIM technology is in consumer electronics, accounting for about 40.3% of the market, followed by the automotive sector [58][60]. - MIM is increasingly utilized in the production of complex components for humanoid robots, electric tools, and automotive parts, showcasing its versatility across various high-end manufacturing sectors [47][49][58]. 4. Competitive Landscape - The MIM industry in China is characterized by a diverse competitive landscape, with key players like Dongmu Co., Haichang New Materials, and Tonglian Precision leading the market [5][61]. - The report emphasizes the importance of technological accumulation and scale effects for leading companies to maintain competitive advantages in the evolving MIM market [53][56].

Investment Rating - The report maintains a "Recommended" rating for China Pacific Insurance (02328.HK) with a target price of HKD 21 [2][8]. Core Insights - In 2025, the company achieved a net profit of CNY 40.4 billion, representing a year-on-year increase of 25.5%. The comprehensive cost ratio (COR) improved to 97.5%, down by 1.3 percentage points. The total investment return rate was 5.8%, up by 0.1 percentage points, and the return on equity (ROE) was 14.7%, an increase of 1.7 percentage points. A final dividend of CNY 0.44 per share (tax included) is proposed [2][8]. - The company maintained its leading position in the insurance market with a market share of 31.6%, achieving original premium income of CNY 555.8 billion, a year-on-year increase of 3.3% [8]. - The profitability of the auto insurance segment was highlighted, with a premium income of CNY 305.7 billion, up by 2.8% year-on-year, and a significant increase in underwriting profit by 53.6% to CNY 14.3 billion [8]. - The investment asset scale reached CNY 760.4 billion by the end of 2025, a year-on-year increase of 12.4%. The company adjusted its investment strategy to increase equity allocation, which helped mitigate bond losses due to interest rate fluctuations [8]. Financial Summary - Key financial indicators for 2025 include: - Insurance service performance: CNY 20.165 billion - Year-on-year growth rate: 40.2% - Net profit attributable to shareholders: CNY 40.370 billion - Earnings per share: CNY 1.82 - Price-to-earnings ratio: 7.29 times - Price-to-book ratio: 1.03 times [4][9].

Investment Rating - The report maintains a "Recommendation" rating for the company, with a target price of 50.3 CNY for 2026, compared to the current price of 37.09 CNY [2][4]. Core Insights - In 2025, the company achieved a net profit attributable to shareholders of 53.5 billion CNY, a year-on-year increase of 19%, and an operating profit of 36.5 billion CNY, up 6.1% year-on-year [2]. - The new business value (NBV) for life insurance increased by 40.1% to 18.6 billion CNY, while the combined ratio (COR) for property insurance improved by 1 percentage point to 97.6% [2]. - The company’s net, total, and comprehensive investment returns were 3.4%, 5.7%, and 6.1%, respectively, with slight year-on-year changes of -0.4 percentage points, +0.1 percentage points, and +0.1 percentage points [2][4]. Financial Performance Summary - The main revenue for 2025 is projected at 435.2 billion CNY, with a year-on-year growth rate of 7.7% [4]. - The net profit attributable to shareholders is expected to reach 58.2 billion CNY in 2026, reflecting an 8.7% year-on-year growth [4]. - Earnings per share (EPS) are forecasted to be 5.6 CNY for 2025, increasing to 6.0 CNY in 2026 [4]. - The price-to-earnings ratio (PE) is projected to decrease from 6.7 in 2025 to 6.1 in 2026 [4]. Business Segment Insights - The life insurance segment showed significant growth, with new business value increasing by 40.1% to 18.6 billion CNY, driven by adjustments in the preset interest rate and the integration of individual insurance sales [8]. - The property insurance segment reported a 0.1% increase in original premiums to 201.5 billion CNY, with a notable improvement in underwriting profit, which surged by 81% to 4.8 billion CNY [8]. - The company is actively reallocating its investment portfolio, increasing its equity investments, particularly in FVOCI stocks, which now account for 37% of its equity investments, reflecting a 7 percentage point increase year-on-year [8].

Investment Rating - The report maintains a "Strong Buy" rating for the company, indicating an expectation to outperform the benchmark index by over 20% in the next six months [4][16]. Core Insights - The company achieved a revenue of 31.01 billion yuan in 2025, representing a year-over-year increase of 11.0%. The net profit attributable to shareholders was 4.06 billion yuan, up 31.1% year-over-year [1][3]. - The report highlights that the company's emerging industries are expected to open new growth opportunities, particularly in the fields of liquid cooling components and robotics [7][8]. Financial Performance Summary - **2025 Financial Results**: - Total revenue: 31.01 billion yuan, YoY +11.0% - Net profit: 4.06 billion yuan, YoY +31.1% - Earnings per share: 0.97 yuan [1][3]. - **2026-2028 Financial Projections**: - Revenue is projected to grow to 35.47 billion yuan in 2026 (+14.4%), 41.67 billion yuan in 2027 (+17.5%), and 48.96 billion yuan in 2028 (+17.5%) [3][8]. - Net profit is expected to reach 4.73 billion yuan in 2026 (+16.4%), 5.51 billion yuan in 2027 (+16.6%), and 6.54 billion yuan in 2028 (+18.7%) [3][8]. Market Position and Valuation - The company has a total market capitalization of approximately 184.61 billion yuan, with a circulating market value of about 161.63 billion yuan [4]. - The target price for the stock is set at 56 yuan, with the current price at 43.87 yuan, indicating significant upside potential [4][8]. Emerging Business Opportunities - The company is leveraging its technological advantages in the liquid cooling components sector and has established partnerships with several liquid cooling system providers, indicating a promising growth trajectory [7][8]. - In the robotics sector, the company has successfully entered the actuator business and is focusing on technological improvements for key product models, which may lead to new growth curves in the future [7][8].

Investment Rating - The report maintains a "Recommend" rating for China Pacific Insurance (601601) with a target price of 50.3 CNY for 2026, compared to the current price of 37.09 CNY [2][4]. Core Insights - In 2025, the company achieved a net profit attributable to shareholders of 53.5 billion CNY, a year-on-year increase of 19%. The operating profit attributable to shareholders was 36.5 billion CNY, up 6.1% year-on-year. The new business value (NBV) for life insurance rose by 40.1% to 18.6 billion CNY, while the combined ratio (COR) for property insurance improved by 1 percentage point to 97.6% [2][4]. - The investment return rates for the group were 3.4% for net investment yield, 5.7% for total investment yield, and 6.1% for comprehensive investment yield, with respective year-on-year changes of -0.4 percentage points, +0.1 percentage points, and +0.1 percentage points [2][4]. Financial Performance Summary - The main revenue for 2025 is projected at 435.2 billion CNY, with a year-on-year growth rate of 7.7%. The net profit attributable to shareholders is expected to reach 53.5 billion CNY, reflecting a growth rate of 19% [4]. - Earnings per share (EPS) for 2025 is estimated at 5.6 CNY, with a price-to-earnings (P/E) ratio of 6.7 times [4]. - The total assets of the company are projected to be 3.14 trillion CNY by 2025, with a debt-to-asset ratio of 89.37% [5][9]. Business Segment Insights - The life insurance segment saw a significant increase in NBV, driven by a 40.1% rise in new business value, attributed to adjustments in the preset interest rate and the integration of individual insurance sales [2][8]. - The property insurance segment reported a 0.1% increase in original premium income, with a notable improvement in the COR, leading to an 81% increase in underwriting profit to 4.8 billion CNY [2][8]. - The company is actively reallocating its investment portfolio, increasing its equity investments, particularly in FVOCI stocks, which now account for 37% of its equity investments, reflecting a strategic focus on stable returns [2][8].

公司研究 稳健兑现，加速进阶 目标价：50 元 调味品 2026 年 03 月 27 日 当前价：36.95 元 华创证券研究所 证券分析师：欧阳予 邮箱：ouyangyu@hcyjs.com 执业编号：S0360520070001 事项： 证 券 研 究 报 告 海天味业（603288）2025 年报点评 强推（上调） 评论： 证券分析师：严文炀 邮箱：yanwenyang@hcyjs.com 执业编号：S0360525070006 证券分析师：董广阳 邮箱：dongguangyang@hcyjs.com 执业编号：S0360518040001 公司基本数据 | 总股本(万股) | 585,182.49 | | --- | --- | | 已上市流通股(万股) | 556,060.05 | | 总市值(亿元) | 2,162.25 | | 流通市值(亿元) | 2,054.64 | | 资产负债率(%) | 15.38 | | 每股净资产(元) | 6.76 | | 12 个月内最高/最低价 | 45.39/34.97 | 市场表现对比图(近 12 个月) -13% -1% 10% 22% 25/03 25 ...

Investment Rating - The report maintains a "Recommend" rating for China Resources Vientiane Life (1209.HK) with a target price of HKD 51.8 [2][7] Core Insights - The company continues to expand its commercial footprint, with impressive performance during the Spring Festival period, indicating strong consumer activity and growth resilience [2][7] - The company opened and renovated 17 commercial projects in 2025, covering over 3 million square meters, with a focus on core cities and regional market expansion [7] - Rental income from operating properties reached RMB 32.94 billion in 2025, showing a year-on-year increase of 13%, with a further 15% growth in early 2026 [7] - The company is expected to maintain rapid growth in 2026, supported by the expansion of flagship projects and innovative business models [7] - The report highlights the company's strong dividend payout policy, reflecting its stable performance in managing shopping centers [7] Financial Summary - Total revenue is projected to grow from RMB 17,043 million in 2024 to RMB 20,698 million in 2027, with a compound annual growth rate (CAGR) of approximately 6.9% [3][8] - Net profit attributable to shareholders is expected to increase from RMB 3,629 million in 2024 to RMB 4,843 million in 2027, with a CAGR of about 9.8% [3][8] - Earnings per share (EPS) is forecasted to rise from RMB 1.59 in 2024 to RMB 2.12 in 2027 [3][8] - The price-to-earnings (P/E) ratio is projected to decrease from 25 times in 2024 to 19 times in 2027, indicating a favorable valuation trend [3][8] - The company’s total market capitalization is approximately HKD 1,025.3 billion, with a circulating market value of HKD 923.78 billion [4]

Investment Rating - The report maintains a "Recommended" rating for the company with a target price of 38.0 CNY [2][8] Core Insights - The company achieved a revenue of 24.35 billion CNY in 2025, representing a year-over-year growth of 8.7%. The net profit attributable to shareholders was 1.01 billion CNY, with a year-over-year increase of 4.4%. However, the non-recurring net profit decreased by 10.1% to 750 million CNY [2][4] - In Q4 2025, the company reported a single-quarter revenue of 6.27 billion CNY, marking a year-over-year growth of 19.4%, and a net profit of 150 million CNY, which is a significant year-over-year increase of 261.8% [2][4] - The company’s main business segments showed steady revenue growth, with the smart control components business generating 12.21 billion CNY, up 18.8% year-over-year, while the smart terminal application business revenue was 11.59 billion CNY, slightly down by 0.4% [8] Financial Performance Summary - The company’s gross margin for 2025 was 20.0%, a decrease of 1.3 percentage points year-over-year. The net profit margin was 4.7%, reflecting a slight increase of 0.1 percentage points [8] - The company’s operating efficiency is expected to improve, with projected earnings per share (EPS) of 1.46 CNY for 2025, increasing to 2.39 CNY by 2028. The price-to-earnings (P/E) ratio is projected to decrease from 23 in 2025 to 14 in 2028 [4][8] - The company’s total assets are projected to grow from 26.14 billion CNY in 2025 to 30.47 billion CNY by 2028, with a debt-to-equity ratio of 33.0% in 2025, decreasing to 27.6% by 2028 [9]

Investment Rating - The report maintains a "Recommend" rating for the company, with a target price of HKD 21 [2][8]. Core Insights - In 2025, the company achieved a net profit of CNY 40.4 billion, representing a year-on-year increase of 25.5%. The comprehensive cost ratio improved to 97.5%, down by 1.3 percentage points. The total investment return rate was 5.8%, up by 0.1 percentage points, and the return on equity was 14.7%, an increase of 1.7 percentage points. A final dividend of CNY 0.44 per share (before tax) is proposed [2][8]. - The company maintained its leading position in the insurance market with a market share of 31.6%, achieving original premium income of CNY 555.8 billion, a year-on-year increase of 3.3% [8]. - The company’s investment assets reached CNY 760.4 billion by the end of 2025, a 12.4% increase from the previous year. The investment strategy was adjusted to increase equity allocation, which helped mitigate bond losses due to rising interest rates [8]. Financial Performance Summary - The company’s insurance service performance is projected to grow significantly, with expected revenues of CNY 51.2 billion in 2025, increasing to CNY 59.8 billion by 2028, reflecting a compound annual growth rate [4]. - The earnings per share (EPS) are forecasted to be CNY 1.82 for 2025, increasing to CNY 2.44 by 2028, with a price-to-earnings (P/E) ratio projected to decrease from 7.29 in 2025 to 5.42 in 2028 [4][8]. - The company’s solvency remains strong, with a debt-to-asset ratio of 65.07% and a net asset value per share of CNY 12.51 [5].

Investment Rating - The report maintains a "Strong Buy" rating for Xuefeng Technology (603227) with an expected performance exceeding the benchmark index by over 20% in the next six months [3][15]. Core Insights - In 2025, Xuefeng Technology faced revenue pressure with a total revenue of 5.564 billion yuan, down 8.81% year-on-year, and a net profit attributable to shareholders of 504 million yuan, down 24.65% year-on-year. However, Q4 showed a positive trend with a net profit of 110 million yuan, up 65.31% year-on-year [1][7]. - The company has a strategic advantage in Xinjiang, enhancing its core asset value and long-term growth potential. The acquisition of additional explosive production capacity is expected to strengthen its competitive position [6][7]. - The chemical segment remains under pressure due to declining prices of major chemical products, although the LNG business showed growth with a revenue increase of 18.7% [6][7]. - The change in controlling shareholder to Guangdong Hongda is seen as a positive signal, with plans for significant asset injections to support future growth [6][7]. Financial Summary - In 2025, the total revenue was 5,564 million yuan, with a projected increase to 6,873 million yuan in 2026, representing a year-on-year growth of 23.5% [7]. - The net profit attributable to shareholders is expected to recover to 769 million yuan in 2026, reflecting a growth rate of 52.7% compared to 2025 [7]. - The company’s earnings per share (EPS) is projected to rise from 0.47 yuan in 2025 to 0.72 yuan in 2026 [7].